These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 27613619)
1. Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis. Farzanehfar P Neurochem Res; 2016 Dec; 41(12):3161-3170. PubMed ID: 27613619 [TBL] [Abstract][Full Text] [Related]
2. Comparative review of adult midbrain and striatum neurogenesis with classical neurogenesis. Farzanehfar P Neurosci Res; 2018 Sep; 134():1-9. PubMed ID: 29339103 [TBL] [Abstract][Full Text] [Related]
3. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases. Pan-Montojo F; Funk RH CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153 [TBL] [Abstract][Full Text] [Related]
4. Harnessing neurogenesis for the possible treatment of Parkinson's disease. Lamm O; Ganz J; Melamed E; Offen D J Comp Neurol; 2014 Aug; 522(12):2817-30. PubMed ID: 24723264 [TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Park HJ; Shin JY; Lee BR; Kim HO; Lee PH Cell Transplant; 2012; 21(8):1629-40. PubMed ID: 22546197 [TBL] [Abstract][Full Text] [Related]
6. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease. Chen W; Huang Q; Ma S; Li M ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716 [TBL] [Abstract][Full Text] [Related]
7. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Yang F; Liu Y; Tu J; Wan J; Zhang J; Wu B; Chen S; Zhou J; Mu Y; Wang L Nat Commun; 2014 Dec; 5():5627. PubMed ID: 25517983 [TBL] [Abstract][Full Text] [Related]
8. Resident adult neural stem cells in Parkinson's disease--the brain's own repair system? van den Berge SA; van Strien ME; Hol EM Eur J Pharmacol; 2013 Nov; 719(1-3):117-127. PubMed ID: 23872414 [TBL] [Abstract][Full Text] [Related]
9. Stem cells and cell replacement therapy for Parkinson's disease. Sonntag KC; Simunovic F; Sanchez-Pernaute R J Neural Transm Suppl; 2009; (73):287-99. PubMed ID: 20411787 [TBL] [Abstract][Full Text] [Related]
16. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Isacson O; Bjorklund LM; Schumacher JM Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105 [TBL] [Abstract][Full Text] [Related]
17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. During MJ; Kaplitt MG; Stern MB; Eidelberg D Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246 [TBL] [Abstract][Full Text] [Related]
18. Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis. Ermine CM; Wright JL; Frausin S; Kauhausen JA; Parish CL; Stanic D; Thompson LH Hippocampus; 2018 May; 28(5):327-337. PubMed ID: 29431270 [TBL] [Abstract][Full Text] [Related]
20. Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Liang CL; Wang TT; Luby-Phelps K; German DC Exp Neurol; 2007 Feb; 203(2):370-80. PubMed ID: 17010972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]